121 related articles for article (PubMed ID: 11516694)
1. The evolution of (99m)Tc-NGA as a clinically useful receptor-binding radiopharmaceutical.
Stadalnik RC; Vera DR
Nucl Med Biol; 2001 Jul; 28(5):499-503. PubMed ID: 11516694
[No Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
Yang W; Mou T; Zhang X; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
[TBL] [Abstract][Full Text] [Related]
4. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
Vera DR; Woodle ES; Stadalnik RC
J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
[TBL] [Abstract][Full Text] [Related]
5. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals.
Koźmiński P; Gniazdowska E
Nucl Med Biol; 2015 Jan; 42(1):28-37. PubMed ID: 25218025
[TBL] [Abstract][Full Text] [Related]
8. In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model.
Stadalnik RC; Kudo M; Eckelman WC; Vera DR
Invest Radiol; 1993 Jan; 28(1):64-70. PubMed ID: 8425855
[No Abstract] [Full Text] [Related]
9. Technetium-99m radiochemistry for pharmaceutical applications.
Papagiannopoulou D
J Labelled Comp Radiopharm; 2017 Sep; 60(11):502-520. PubMed ID: 28618064
[TBL] [Abstract][Full Text] [Related]
10. [Study on technetium-99m in radiopharmaceuticals].
Ding HJ; Yang CC
Kaohsiung J Med Sci; 1996 Mar; 12(3):132-44. PubMed ID: 8709180
[TBL] [Abstract][Full Text] [Related]
11. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
[TBL] [Abstract][Full Text] [Related]
12. Prospective Randomized Trial of Use of In-House Prepared Low-Cost Radiopharmaceutical Versus Commercial Radiopharmaceutical for Sentinel Lymph Node Biopsy in Patients with Early Stage Invasive Breast Cancer.
Agarwal G; Rajan S; Mayilvaganan S; Mishra A; Krishnani N; Gambhir S
World J Surg; 2018 May; 42(5):1391-1395. PubMed ID: 29383426
[TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin.
Vera DR; Stadalnik RC; Kudo M; Krohn KA
Methods Enzymol; 1994; 247():402-9. PubMed ID: 7898368
[No Abstract] [Full Text] [Related]
14. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
Vera DR; Stadalnik RC; Krohn KA
J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
[TBL] [Abstract][Full Text] [Related]
15. Receptor binding ligands to image infection.
Chianelli M; Boerman OC; Malviya G; Galli F; Oyen WJ; Signore A
Curr Pharm Des; 2008; 14(31):3316-25. PubMed ID: 19075710
[TBL] [Abstract][Full Text] [Related]
16. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-L,L-ethylenedicysteine is more effective than technetium-99m diethylenetriamine penta-acetic acid for excluding obstruction in patients with pyelocalicinal dilation.
Lima MC; de Lima ML; Pepe CF; Etchebehere EC; Santos AO; Amorim BJ; Camargo EE; Ferreira U; Palma PC; Ramos CD
Urology; 2010 Aug; 76(2):283-8. PubMed ID: 20206974
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of routine radiochemical quality assurance testing of technetium Tc 99m radiopharmaceuticals.
Ponto JA; Ponto LL
Am J Hosp Pharm; 1986 May; 43(5):1218-22. PubMed ID: 3087163
[TBL] [Abstract][Full Text] [Related]
19. Discordant hepatic uptake of Tc-99m NGA and Tc-99m PMT in a patient with hepatoma.
Aburano T; Shuke N; Yokoyama K; Tonami N; Hisada K; Tanei M; Terada M; Unoura M; Kobayashi K
Clin Nucl Med; 1992 Oct; 17(10):793-6. PubMed ID: 1330392
[TBL] [Abstract][Full Text] [Related]
20. Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced
Meléndez-Alafort L; Ferro-Flores G; De Nardo L; Bello M; Paiusco M; Negri A; Zorz A; Uzunov N; Esposito J; Rosato A
Med Phys; 2019 Mar; 46(3):1437-1446. PubMed ID: 30661241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]